Ypsomed expands the distribution of mylife OmniPod in Europe

Press Releases Ypsomed Group

Burgdorf – From March 2016 the Ypsomed Group will be gradually introducing the tubing free insulin patch pump mylife OmniPod for distribution via existing Group companies also in France, Finland, Denmark, Ireland and Luxembourg. In so doing Ypsomed is taking a considerable step towards expanding the growth basis of its diabetes supply business.

Lees meer...

Ypsomed to start supply of insulin pen developed on the YpsoPen platform to Ukraine

Press Releases Ypsomed Group

Burgdorf – The reusable and affordable YpsoPen is becoming more and more popular. In the coming weeks, it will be supplied to Ukraine. The pharma company Indar, a private joint-stock company (PrJSC), is launching the insulin pen developed in Switzerland.

Lees meer...

Ypsomed intensifies partnership with Tonghua Dongbao Pharmaceutical

Press Releases Ypsomed Group

Burgdorf – Dongbao has been appointed the exclusive distributor for Ypsomed's mylife Clickfine pen needles in China.

Lees meer...

Ypsomed creates new jobs and invests in Solothurn facility

Press Releases Ypsomed Group

Burgdorf – A significant part of this extension is yet another major project for long-standing partner Sanofi.

Lees meer...

Ypsomed is investing in the future

Press Releases Ypsomed Group

Burgdorf – The Ypsomed Group will also be securing its position as a technology leader in the field of injection and infusion systems well into the future.

Lees meer...